Calcium dobesilate reduces VEGF signaling by interfering with heparan sulfate binding site and protects from vascular complications in diabetic mice

Inhibiting vascular endothelial growth factor (VEGF) is a therapeutic option in diabetic microangiopathy. However, VEGF is needed at physiological concentrations to maintain glomerular integrity; complete VEGF blockade has deleterious effects on glomerular structure and function. Anti-VEGF therapy i...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:PLoS One
Auteurs principaux: Njau, Florence, Shushakova, Nelli, Schenk, Heiko, Wulfmeyer, Vera Christine, Bollin, Robin, Menne, Jan, Haller, Hermann
Format: Artigo
Langue:Inglês
Publié: Public Library of Science 2020
Sujets:
Research Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC6959593/
https://ncbi.nlm.nih.gov/pubmed/31935212
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0218494
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires